We may earn a commission from partner links. It never changes our math or the order.How we make money
CravingWise
Free ebook
Comparison

Ozempic vs Wegovy vs Zepbound

For weight-management comparisons, start with Wegovy and Zepbound because their labels include chronic weight-management uses.

Good for

  • Readers trying to understand semaglutide versus tirzepatide before comparing providers.
  • People checking whether a quoted medication is FDA-approved for weight management.
  • Users who need clear language before a telehealth intake or pharmacy quote.

Read the comparison

Comparison standard

Keep the comparison focused on verifiable differences: medication path, advertised price, membership terms, product type, support model and final checkout questions.

  • Normalize cost
  • Name product type
  • Link to provider reviews

Active ingredient and label are separate questions

Ozempic and Wegovy both contain semaglutide, but the label, dose schedule and approved-use language differ. Ozempic's FDA label is built around type 2 diabetes uses and related risk-reduction language. Wegovy's label is built around chronic weight management, cardiovascular risk-reduction language for selected adults and other current label details. Zepbound is different again because it contains tirzepatide, a GIP/GLP-1 receptor agonist, and has its own prescribing information.

  • Same active ingredient does not mean same product label.
  • Ask whether the provider is using a medication on-label or off-label.
  • Use FDA labels, not social posts, as the source of truth for approved uses.

Weight-management comparison

If the question is chronic weight management, Wegovy and Zepbound are the cleaner starting points because their official labels include weight-management uses. Ozempic may still appear in provider conversations, but for weight loss that usually means off-label prescribing. Off-label use is a clinician decision, not a marketing shortcut, and it should come with clear explanation of risks, alternatives and monitoring.

  • Do not assume Ozempic is FDA-approved for weight loss because it is a GLP-1 medicine.
  • Compare Wegovy and Zepbound using their own labels and dose paths.
  • Ask how side effects, missed doses and contraindications are handled.

Safety and cost checks before choosing

All three products have prescribing information that clinicians use to screen for contraindications, warnings, drug interactions and adverse reactions. Cost comparisons also need precision: insurance may treat diabetes and obesity indications differently, and cash-pay pricing can differ by product, dose, pharmacy and savings program. The safest consumer workflow is to confirm the exact brand, active ingredient, indication and total out-of-pocket cost before paying a provider.

  • Confirm brand name, active ingredient and dosage form.
  • Check whether insurance approval depends on diagnosis or prior authorization.
  • Review boxed warnings and contraindications with a licensed clinician.

Quick answers

What is the fairest way to compare these options?

Use the same evidence set for each option: total recurring quote, medication path, support model, source quality and unresolved checkout questions.

Sources (5)

Sources

  1. FDA label: Ozempic prescribing informationFDA-approved semaglutide diabetes label.
  2. FDA label: Wegovy prescribing informationFDA-approved semaglutide weight-management label.
  3. FDA label: Zepbound prescribing informationFDA-approved tirzepatide weight-management label.
  4. Wegovy: official patient informationManufacturer page linking Wegovy prescribing information and patient-facing indication language.
  5. Zepbound: official patient informationManufacturer patient page describing Zepbound use for adults with obesity or overweight with weight-related problems and OSA context.

Verify before purchase

  • Final checkout quote after eligibility screening
  • Medication type, pharmacy route and FDA-approved or compounded status
  • Renewal, cancellation, refund and refill terms
Read the full comparison

What to verify

  • Final checkout quote after eligibility screening
  • Medication type, pharmacy route and FDA-approved or compounded status
  • Renewal, cancellation, refund and refill terms
Review overview

This comparison should keep product names, indications and official labels clear so readers do not treat every GLP-1 topic as interchangeable.

Last checked Jul 5, 2026

Medication boxes and clinical supplies used for comparing prescription options.

Comparison standard

Keep the comparison focused on verifiable differences: medication path, advertised price, membership terms, product type, support model and final checkout questions.

  • Normalize cost
  • Name product type
  • Link to provider reviews

Active ingredient and label are separate questions

Ozempic and Wegovy both contain semaglutide, but the label, dose schedule and approved-use language differ. Ozempic's FDA label is built around type 2 diabetes uses and related risk-reduction language. Wegovy's label is built around chronic weight management, cardiovascular risk-reduction language for selected adults and other current label details. Zepbound is different again because it contains tirzepatide, a GIP/GLP-1 receptor agonist, and has its own prescribing information.

  • Same active ingredient does not mean same product label.
  • Ask whether the provider is using a medication on-label or off-label.
  • Use FDA labels, not social posts, as the source of truth for approved uses.

Weight-management comparison

If the question is chronic weight management, Wegovy and Zepbound are the cleaner starting points because their official labels include weight-management uses. Ozempic may still appear in provider conversations, but for weight loss that usually means off-label prescribing. Off-label use is a clinician decision, not a marketing shortcut, and it should come with clear explanation of risks, alternatives and monitoring.

  • Do not assume Ozempic is FDA-approved for weight loss because it is a GLP-1 medicine.
  • Compare Wegovy and Zepbound using their own labels and dose paths.
  • Ask how side effects, missed doses and contraindications are handled.
The check we would not skip
Ozempic is not the same label as Wegovy even though both use semaglutide.
The check we would not skip · CravingWise research desk

Safety and cost checks before choosing

All three products have prescribing information that clinicians use to screen for contraindications, warnings, drug interactions and adverse reactions. Cost comparisons also need precision: insurance may treat diabetes and obesity indications differently, and cash-pay pricing can differ by product, dose, pharmacy and savings program. The safest consumer workflow is to confirm the exact brand, active ingredient, indication and total out-of-pocket cost before paying a provider.

  • Confirm brand name, active ingredient and dosage form.
  • Check whether insurance approval depends on diagnosis or prior authorization.
  • Review boxed warnings and contraindications with a licensed clinician.
More questions and context

Decision filter

Product names and labels matter

A comparison is useful only when it separates confirmed facts from terms that still depend on eligibility, insurance, dose or checkout.

  • Cost
  • Medication path
  • Support model
  • Open questions

Common questions

What is the fairest way to compare these options?

Use the same evidence set for each option: total recurring quote, medication path, support model, source quality and unresolved checkout questions.

Educational content only. Do not use this page as medical advice or as a substitute for a licensed clinician, pharmacist or insurer reviewing your situation.

Related checks
Sources and what to verify (5)

Sources

  1. FDA label: Ozempic prescribing information

    FDA-approved semaglutide diabetes label.

  2. FDA label: Wegovy prescribing information

    FDA-approved semaglutide weight-management label.

  3. FDA label: Zepbound prescribing information

    FDA-approved tirzepatide weight-management label.

  4. Wegovy: official patient information

    Manufacturer page linking Wegovy prescribing information and patient-facing indication language.

  5. Zepbound: official patient information

    Manufacturer patient page describing Zepbound use for adults with obesity or overweight with weight-related problems and OSA context.